2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Filip Krag Knop: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-bariatric Hypoglycaemia Dasiglucagon, HyoPen, Placebo - Hyperinsulinemic Hypoglycemia, Postprandial Hypoglycemia | Phase 2 | Completed | Filip Krag Knop | 24 | 2021-08-20 | 2023-02-02 |
| Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases Exenatide, Placebos - Diabetes Mellitus, Type 1 | Phase 2 | Completed | Filip Krag Knop | 108 | 2016-12-01 | 2019-07-10 |
Congenital Hyperinsulinism (1) · Diabetes Mellitus, Type 1 (1) · Hypoglycemia (1) · Insulin Resistance (1)
Exenatide (1) · dasiglucagon (1)
Denmark (2)